Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-21-044516

President sold 25,000 shares at $165.00 ($4,125,000)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Novak Rodger President 2021-06-30 Sale −25,000 $165.00 $4,125,000 573,007 D
Open-market sales · 25,000 sh · avg $165.00 · $4,125,000
Loading xslF345X03/doc4.xml…